Recent meta-analyses of GWA studies revealed fasting glucose-raising variants in CRY2 which, surprisingly, were not robustly associated with an increased risk for type-2 diabetes [23,24]. This evidence concerns the gene CRY2 and type 2 diabetes mellitus.